Phosphorylation of p34Cdc2 can both positively and negatively regulate its kinase activity. We have mapped two phosphorylation sites in Xenopus p34cdc2 to Thr-14 and Tyr-15 within the putative ATP-binding region of p34cdc2. Mutation of these sites to Ala-14 and Phe-15 has no effect on the final histone Hi kinase activity of the cyclin/p34cdc2 complex. Phosphopeptide analysis shows that there is at least one more site of phosphorylation on p34cdc2. When Thr-161 is changed to Ala, two phosphopeptide spots disappear and it is no longer possible to activate the Hi kinase activity of p34cdc2. We suggest that Thr-16i is a third site of phosphorylation, which is required for kinase activity. All three phosphorylations are induced by cyclin. None of the phosphorylations appears to be required for binding to cyclin, as indicated by the ability of the triple mutant, Ala-14, Phe-15, Ala-161, to bind cyclin. The activating phosphorylation that requires Thr-or Ser-161 occurs even in a catalytically inactive K33R mutant of p34cdc2 and hence does not appear to be the result of intramolecular autophosphorylation. We have detected an activity in Xenopus extracts required for activation of p34cdc2 and present evidence that this is a p34cdc2 activating kinase which, in a cyclin-dependent manner, probably directly phosphorylates Thr-161.
INTRODUCTION
p34cdc2 is regulated by both association with cyclin and by multiple phosphorylations. Phosphorylation sites have been mapped in two organisms. In Schizosaccharomyces pombe, Tyr-15 is phosphorylated in G2 and is abruptly dephosphorylated on entry into mitosis (Gould and Nurse, 1989) . Mutagenesis has indicated that this phosphorylation negatively regulates p34cdc2 activity, consistent with its location within the putative ATPbinding region of p34cdc2. Phosphorylation sites have also been determined for chicken p34 c2 (Krek and Nigg, 1991) . Similar to S. pombe, chicken p34cdc2 iS phosphorylated on Tyr-15, as well as on the adjacent . Phosphorylation also occurs on Ser-277 during Gl and on a threonine that may correspond to during mitosis. The Thr-161 homologous residue is also believed to be phosphorylated in S. pombe p34cdc2 (cited in Krek and Nigg, 1991) . It is generally believed that homologs of the S. pombe weel+ gene product phosphorylate , although definitive proof is lacking (Featherstone and Russell, 1991; Parker et al., 1991) . There are currently no candidates for other kinases, although autophosphorylation of p34cdc2 on Thr-161 has been proposed because this site aligns with an autophosphorylation site found in a number of kinases (Krek and Nigg, 1991) .
We recently examined the phosphorylation of p34CdC2 that occurred after the addition of purified cyclin protein to an interphase extract derived from Xenopus eggs (Solomon et al., 1990) . Monomeric p34cdc2 was unphosphorylated and inactive. Binding to cyclin induced the phosphorylation of p34cdc2 on at least three sites, two threonines and a tyrosine. (Cyclin-induced tyrosine phosphorylation of p34cdc2 has also been reported by Parker et al., 1991 and by Meijer et al., 1991.) Phosphorylation of the tyrosine and a nearby threonine was transient, serving to keep these newly formed complexes inactive until a threshold concentration of cyclin/p34cdc2 complexes was formed. Phosphorylation of the second threonine persisted into mitosis; dephosphorylation of this threonine in vitro led to inactivation of the complex . Although inhibitory phosphorylations of p34cdc2 OCcurred immediately on cyclin binding, the timing of the activating phosphorylation and whether it is induced by cyclin binding, as opposed to being trapped in the presence of cyclin, were not explored.
To understand the nature and sequence of the phosphorylation reactions, it is necessary to map these phosphorylation sites. We have now determined the probable sites of phosphorylation of Xenopus p34cdc2, using recombinant p34cdc2 produced from the cloned gene (Milarski et al., 1991) , purified cyclin protein, and interphase extracts derived from Xenopus eggs. After the identification of the sites we hope to identify the responsible kinases and ultimately to describe their regulation. Using various mutated forms of p34cdc2, it is possible to distinguish autophosphorylation from phosphorylation driven by other kinases. From these experiments we have found that none of these phosphorylations is the result of autophosphorylation. The phosphorylation of the activating site on p34cdc2 must therefore be due to an unidentified kinase activity. Using a specific assay for this activity, we have purified this kinase 100-fold. We have termed this the p34cdc2 activating kinase (CAK). CAK activates p34cdc2 by phosphorylation, probably on Thr-161, only in the presence of cyclin.
MATERIALS AND METHODS

Buffers
The following buffers were used extensively throughout this work: XB, 100 mM KC1, 50 mM sucrose, 1 mM MgCl2, 0.1 mM CaCl2, 10 mM K-N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), pH 7.4, with 10 ,g/ml each of leupeptin, chymostatin, and pepstatin; EB, 15 mM MgCl2, 20 mM ethylene glycol-bis(3-aminoethyl ether)-N,N,NM,N'-tetraacetic acid (EGTA), 10 mM dithiothreitol (DTT), 80 mM K-,B-glycerophosphate, pH 7.3, containing 25 ytg/ml aprotinin, 25 Ag/ml leupeptin, 1 mM benzamidine, 0.5 mM phenylmethylsulfonyl fluoride, 10 Mug/ml pepstatin; buffer A, 50 mM NaCl, 1 mM DTT, 1 mM MgCl2, 0.1 mM EDTA, 20 mM triethanolamine (pH 8.0 at 4°C) containing 10 uig/ml each of leupeptin, chymostatin, and pepstatin; and RIPA, 150 mM NaCl, 1.0% NP-40, 1.0% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 20 mM K-HEPES, pH 7.4 and containing 10 Mg/ml each of leupeptin, chymostatin, and pepstatin.
Extracts and Hi Kinase Assays
Preparation of Xenopus interphase extracts (Solomon et al., 1990) and Xenopus oocyte extracts (Cyert and Kirschner, 1988) has been described. Hi kinase assays were performed exactly as described (Solomon et al., 1990 ).
Proteins and Other Reagents
Okadaic acid was purchased from Moana Bioproducts (Honolulu, Hawaii). p13sucl-Sepharose, glutathione S-transferase cyclin B (GTcyclin B) containing an N-terminal fusion of glutathione S-transferase to a sea urchin type B cyclin, and an anti-PSTAIR antiserum were prepared exactly as described previously (Solomon et al., 1990) . A similar fusion to clam cyclin A was purified in the same manner. The 12CA5 monoclonal antibody to the peptide YPYDVPDYA in the influenza hemagglutinin protein (Wilson et al., 1984; Field et al., 1988) was generously provided by Laura Davis (Whitehead Institute, Cambridge, MA).
Expression of Xenopus p34CdC2 in reticulocyte lysates has been described . 35S-labeled p34cdc2 was produced at -6 ng/lA at a specific activity of -3 X 105 cpm/jul. Extracts were supplemented with 0.4 mM L-Methionine for translation of unlabeled p34cdc2 (-12 ng/lA). A clone of the Xenopus p34cdc2 gene was generously provided by K. Milarski and J. Newport (UCSD). Singlestranded uracil-containing p34Cdc2 DNA was mutagenized (Zoller and Smith, 1984; Kunkel, 1985) using the following oligonucleotides T14A: GATCGGAGAGGGCGCATATGGGGTTGTGTAC Y15F: GATCGGAGAGGGCACATTTGGGGTTGTGTAC T14A, Y15F: GATCGGAGAGGGCGCATTTGGGGTTGTGTAC K33R: GTTGTTGCAATGCGCAAAATTCGATTG K34R: GTTGCAATGAAGCGCATTCGATTGG T161A: CGGGTTTACGCGCATGAGGTA
The triple mutant containing T14A, Y15F, and T161A was constructed by swapping Bsm I-BamHI fragments (position 458 to the polylinker beyond the 3' end of the gene).
Purification of Hi Kinase
Hi kinase was purified from a Xenopus extract to which GT-cyclin B was added, by virtue of the glutathione S-transferase tag on cyclin B. Four hundred microliters of interphase extract was incubated with 400 Ml of GT-cyclin B in XB (125 nM final GT-cyclin B concentration) for 20 min at 23°C. This mixture was added to 800 Ml of glutathioneagarose beads (S-linkage, Sigma, St. Louis, MO) that had been washed extensively with XB/0.5% NP-40/0.5 M NaCl followed by EB. After 20 min at 23°C, the beads were pelleted and washed in 10 ml once with EB, once with EB/0.2% NP-40, twice with EB/0.2% NP-40/0.5 M NaCl, and twice with EB. GT-cyclin B/p34cdc2 complexes were eluted with three 0.8-ml volumes of EB/5 mM glutathione (reduced, freshly prepared)/0.1 mg/ml ovalbumin/0.05% NP-40/8% (vol/vol) glycerol/0.1 mM ATP. The pooled eluate was centrifuged briefly to pellet any remaining beads. The supematant was concentrated in Centricon-30 cells (Amicon, Danvers, MA) to 230 Ail, aliquoted, frozen in liquid nitrogen, and stored at -80°C.
Binding of 35S-Labeled p34cdc2 to Cyclin, p13sc1, and the 12CA5 Monoclonal Antibody For binding to cyclin and to p13sucl, 1.0 gl of a 35S-labeled reticulocyte lysate containing the Y15F form of p34cdc2 was diluted with 20 ul of XB/0.1 mg/ml ovalbumin with or without 5 mM EDTA. For native immunoprecipitation, 1.0,ul of the reticulocyte lysate was diluted with 20,Ml of XB/0.1 mg/ml ovalbumin/1% NP-40. This was added to 20 Ml of beads containing GT-cyclin B, p138uc1, or the 12CA5 antibody.
For cyclin binding, glutathione agarose beads (S-linkage, Sigma) were washed twice with 150 mM NaCl, 0.5% NP-40, 5 mM DTT, 2 mM EDTA, 50 mM tris(hydroxymethyl) aminomethane (Tris), pH 8.0, containing 10 Mig/ml each of leupeptin, chymostatin, and pepstatin, incubated with -250 nM GT-cyclin B for 20 min, washed twice more with 150 mM NaCl, 0.5% NP-40, 5 mM DTT, 2 mM EDTA, 50 mM Tris, pH 8.0, containing 10 Mg/ml each of leupeptin, chymostatin, and pepstatin, and three times with XB. Control glutathione-agarose beads were washed similarly but were not incubated with GT-cyclin B. One sample was washed a final time with XB containing 5 mM EDTA. pl3sucl-Sepharose beads were washed once with XB/0.5 M NaCl/0.5% NP-40 and twice with XB. A final rinse with XB/5 mM EDTA was performed on appropriate samples. For immunoprecipitation, 20 Ml of protein A-Sepharose beads was washed three times with XB/1% NP-40, incubated for 60 minwith 2Mgl (4 MAg) of 12CA5 (Solomon et al., 1990) . All precipitations (GT-cycin B, p13suc , and immunoprecipitation) were as described (Solomon et al., 1990) . Twelve and one-half microliters of 12CA5 antibody (-25 ug) and 25,Ml of protein A-Sepharose beads were used per sample. Digestion of eluted p34cC2 with trypsin, electrophoresis at pH 1.9 in acetic acid/formic acid/H20 (195:65:1040) , and chromatography in n-butanol/pyridine/acetic acid/H20 (75:50:15:60) were as described (Solomon et al., 1990; Ward and Kirschner, 1990 26 ,Ml of EB containing 1 mg/ml ovalbumin was added and the samples were frozen in liquid nitrogen before assay of Hi kinase activity exactly as described (Solomon et al., 1990) . When indicated, control reactions contained all components except the reticulocyte extract, which was replaced with EB.
Partial Purification of the p34cdc2 Activating Kinase Two milliliters of an interphase extract (-140 mg protein) was diluted with 18 ml of buffer A and centrifuged at 40 000 X g for 30 min at 4°C in the SW50.1 rotor (Beckman, Fullerton, CA). The supematant (-120 mg) was applied from below to an 8 ml DEAE-Sepharose column (1.0-cm diameter column) pre-equilibrated with buffer A. The column was run downward at 20 ml/h and 1-ml fractions were collected. The column was washed with 20 ml of buffer A after the sample was applied. A 100-ml linear gradient from buffer A to buffer A/400 mM NaCl was applied to the column. The protein concentrations of the fractions were determined using the Bradford assay (BioRad, Richmond, CA) with bovine serum albumin as standard, and the NaCl concentrations were determined by conductivity measurements. Activity eluted with a peak at 115 mM total NaCl. Purification was sixfold with nearly complete recovery of activity. Activity in the pooled fractions was precipitated from 38% ammonium sulfate and resuspended in 4% of the input volume in buffer A for a further 5-to 10-fold purification with near quantitative recovery of activity. Gel filtration chromatography was performed on a Bio-Sil TSK-250 column (300 mm X 7.5 mm, Bio-Rad). The column was equilibrated in buffer A. The flow rate was 0.4 ml/min and 1-min fractions were collected. One hundred microliters of the resuspended ammonium sulfate precipitate was applied. wild-type or mutant p34cdc2 proteins ('-12 ng/Ml) and 60 Ml of XB/ 1% NP-40/1 mg/ml ovalbumin were added. After 20 min on ice, the beads were pelleted, rinsed twice in XB/1% NP-40, twice in EB, once in EB/1 mg/ml ovalbumin, and further aliquoted. To these beads, 3,l of GT-cyclin B (830 nM in EB/1 mg/ml ovalbumin) or EB/1 mg/ ml ovalbumin alone, 3 Ml of p34cdc2 activating kinase (or EB/1 mg/ ml ovalbumin alone), and 3 Ml of an ATP mix made up of 30 Ml of [y-32P]ATP (7.8 mCi/ml, 3000 Ci/mmol, ICN, Costa Mesa, CA), 2.7
Ml of 1 mM ATP, and 7.3 Ml of EB/1 mg/ml ovalbumin were added.
The p34IC2 activating kinase fraction was purified through the ammonium sulfate fractionation and was at a concentration of -1.7 mg/ml. After 20 min at 23°C, the beads were pelleted and rinsed once in EB/0.2% NP-40, twice in RIPA buffer containing 0.25 M LiCl, once in RIPA buffer, once in 20 mM K-HEPES (pH 7.4), and resuspended in sample buffer for SDS-polyacrylamide gel electrophoresis on 5-15% gradient gels.
Treatment of p34cdc2 Activating Kinase With p13sucl-Sepharose Beads
Partially purified p34cdC2 activating kinase (through the DEAE column, --1.4 mg/ml) was incubated with an equal volume of either protein A-Sepharose beads or p13sucl-Sepharose beads. The beads were first rinsed twice with XB/0.5% NP-40/0.5 M NaCl and twice with buffer A. After 30 min on ice, the beads were pelleted. The supematant was saved and the pellet was rinsed two times with buffer A and resuspended in sample buffer. The supematants and the starting material were assayed for p34cdc2 activating kinase activity as described above.
Immunoblotting
Transfer and detection were as described before (Solomon et al., 1990) , except that the secondary antibody was horseradish peroxidase conjugated donkey anti-rabbit with development using the enhanced chemiluminescence method (Amersham, Arlington Heights, IL). The anti-PSTAIR serum was affinity purified on the 17 amino acid (including N-terminal cysteine) PSTAIR peptide.
RESULTS
Production of Functional p34cdc2 In Vitro
The only expression system we have found suitable for production of activatable p34cdc2 iS in vitro translation in reticulocyte lysates , which can produce p34cdc2 at about the same concentration as is found within a Xenopus extract. The first indication of the structural fidelity of this protein was its ability to bind to known p34cdc2-binding proteins, cyclin and p13sucl ( Figure 1 ). The cyclin was GT-cyclin B, a fusion of glutathione S-transferase to a sea urchin type B cyclin, expressed in Escherichia coli and affinity purified on glutathione-agarose beads (Solomon et al., 1990 actions because binding occurred even in the presence of 5 mM EDTA (Figure 1 , lanes 4, 6, and 8). The p34cdc2 was produced with a C-terminal 14 amino acid extension derived from the influenza hemagglutinin protein, a peptide recognized by the 12CA5 monoclonal antibody (Wilson et al., 1984; Field et al., 1988) . This antibody efficiently precipitated the recombinant p34cdc2 and H), wild-type p34cdc2 expressed in a reticulocyte lysate (E and F), or mutant forms of p34'Cdc2 expressed in a reticulocyte lysate (T161A, B and G; T14A, C) were 32P-labeled in an interphase extract after addition of cyclin. A-D show extracts blocked from entering mitosis by 2 mM vanadate. E-H show extracts in mitosis. F is a longer exposure of E, to match the exposure of G. GT-cyclin B was added to 250 nM (A-C and E-G) and GT-cyclin A was added to 400 nM (D and H). p34cdc2 was purified for phosphopeptide analysis from all extracts by p13sucu precipitation followed by immunoprecipitation (anti-PSTAIR for A, D, and H and 12CA5 for B, C, E, F, and G). D and H and B, C, E, F, and G (Figure 2A, lane 4) . This background was further reduced by more stringent washing of the beads ( Figure 2B ). [Milarski et al., 1991] .) Mutation of these residues to Ala-14 and Phe-15 had no effect on the activatability of p34cdc2 ("AF" mutant; Figure 2B , compare lanes 1 and 2), indicating that p34cdc2 need not pass through an inactivated intermediate form as an obligate step on the activation pathway. On the other hand, mutation of a conserved lysine involved in ATPbinding by kinases (Hanks et al., 1988) abolished p34cdc2 activity (K33R, Figure 2B , lane 3; see also Booher and Beach, 1986) , whereas mutation of the adjacent lysine was without effect (K32R, Figure 2B , lane 4). Mutation of Thr-161 to a nonphosphorylatable Ala also prevented activation, regardless of whether Thr-14 and Tyr-15 were mutated to Ala/Phe ( Figure 2C , lanes 2 and 6), although mutation to a phosphorylatable Ser permitted activation ( Figure 2C , lanes 4 and 8). Mutation to Glu, in an attempt to mimic a phosphorylated amino acid, blocked activity ( Figure 2C, lanes 3 and 7) . Similarly, we found that the Asp-161 mutation also blocked activity. The strict dependence on a phosphorylatable amino acid at position 161 is consistent with the multiple structural interactions made by the equivalent phosphorylated amino acid in the cAMP-dependent protein kinase (Knighton et al., 1991) .
closely spaced doublet, with a relatively faint upper band (see, e.g., Figure 3 , lane 1). This upper band does not comigrate with either of the strong electrophoretically retarded bands corresponding to phosphorylated p34cdc2. Phosphorylation of wild-type p34cdc2 in a vanadate arrested extract led to the appearance of two slower migrating rungs of a ladder. These new forms did not appear in the "AF" double mutant, T14A/Y15F (Figure 3, lane 4) . The single mutants had a maximum one-rung retardation (Figure 3, lanes 6 and 8) ; this was clearer for the T14A mutant because vanadate treatment leads to higher stoichiometry phosphorylation of Tyr-15 than of Thr-14. Thus, each unit of retardation reflects an incremental phosphorylation of p34Cdc2; the phosphorylated sites are Thr-14 and Tyr-15. Phosphorylation of Thr-14 and Tyr-15 occurred even in the context of Thr-161 mutations (Figure 3, lanes 9-14) . There appeared to be less phosphorylation of these sites in the inactive forms (Figure 3 , lanes 10 and 14) than in the Ser-161 mutant (Figure 3, lane 12) . We do not know if this perceived reduction is genuine or if the second incremental retardation requires Thr-161 phosphorylation. As shown below by direct 32P-labeling, both Thr-14 and Tyr-15 are phosphorylated in the T161A mutant ( Figure 4B ). p34cdc2 phosphorylation sites were also analyzed by direct peptide mapping (Figure 4) . p34cdc2, either endogenous or in vitro translated in a reticulocyte lysate, was 32P-labeled in a Xenopus interphase extract after addition of GT-cyclin B. p34cdc2 phosphorylation sites were examined in mitotic extracts (Figure 4 , E-H) and in extracts that were incubated with 2 mM vanadate to prevent p34cdc2 dephosphorylation on tyrosine to block entry into mitosis; this leads to the accumulation of p34cdc2 phosphorylated on all sites (Solomon et al., 1990) ( Figure 4, A-D) . The endogenous p34cdc2 gave rise to ck,A\OC) A\b Phosphorylation Sites on p34cdc2
We have taken advantage of the electrophoretic retardation conferred on p34cdc2 by inhibitory phosphorylation (Solomon et al., 1990; Kumagai and Dunphy, 1991) to determine these sites. 35S-labeled p34cdc2 made in reticulocyte lysates was incubated with GT-cyclin B in an interphase extract in the presence of 2 mM vanadate to prevent entry into mitosis by blocking tyrosine dephosphorylation of p34cdc2 (Morla et al., 1989; Solomon et al., 1990) . This treatment traps wild-type p34cdc2 in a triply phosphorylated intermediate state that is phosphorylated on a tyrosine, a nearby threonine, and a second threonine (Solomon et al., 1990 2.5 nM five labeled peptides ( Figure 4A ). Peptide 1 contained both phosphotyrosine and phosphothreonine, and we suggested that it was a doubly phosphorylated version of peptide 2, which contained only phosphotyrosine (Solomon et al., 1990) . Peptides 4 and 5, which persisted into mitosis (Figure 4 , E and F), contained only phosphothreonine (Solomon et al., 1990 Figure 4B ) and from the mitotic extract ( Figure 4G ). Traces of residual phosphorylation of Thr-14 and of Tyr-15 were visible (Figure 4 , F and G). (Note that the labeling and exposure conditions in F and G were identical for the wild-type and T161A mutant of the recombinant p34cdc2.) We interpret these results to indicate that peptides 4 and 5 contain the same phosphorylation site and that incomplete digestion by trypsin gives rise to two phosphorylated peptides. We cannot exclude the possibility that a second phosphorylation occurs that is absolutely dependent on the first. As the simplest interpretation, we will refer to this phosphorylation as occurring on a single site, Thr-161. Further experiments are in progress to clarify these points.
We determined the phosphorylation sites of p34cdc2 induced by a type A cyclin to see whether these could account for the different activation kinetics and behaviors of p34cdc2 in response to type A and B cyclins (Minshull et al., 1990; Solomon et al., 1991 . Figure 4 demonstrates that peptides 4 and 5 are also phosphorylated in both a vanadate-arrested extract ( Figure 4D ) and in a mitotic extract ( Figure 4H ). This experiment also confirms the cyclin A-induced phosphorylation of Tyr-15 ( Figure 4D) Figure 5 , lanes 2, 3, 6, and 7) or not (Ala; Figure 5 , lanes 4 and 5), and was independent of the presence of nonphosphorylatable amino acids at residues 14 and 15.
Putative T161 Phosphorylation does not Require Activation of the Mitotic State but Requires Cyclin Binding It is important to understand whether the phosphorylation that seems to occur on Thr-161 is a consequence of mitosis or a prerequisite for mitosis. A test of this is to determine whether this phosphorylation occurs at subthreshold concentrations of cyclin. Our previous analysis (Solomon et al., 1990) showed that this site was phosphorylated in mitotic and vanadate-arrested extracts containing high concentrations of GT-cyclin B but did not indicate whether this activating phosphorylation also occurred at low concentrations of cyclin, such as are present during interphase, before the decision to enter mitosis. To answer this question, we ex- concentrations of GT-cyclin B (Figure 6 ). In this experiment, the threshold concentration for p34cdc2 activation was 38 nM ( Figure 6C ). The amount of 32P-orthophosphate used and the exposure times of the autoradiograms were adjusted to produce equal sensitivities in the presence of varying cyclin concentrations (see Figure  6 legend). Relative to phosphorylation of Tyr-15, peptides 4 and 5 were equally phosphorylated in a vanadate-arrested extract ( Figure 6A ) and at subthreshold GT-cyclin B concentrations ( Figure 6 , D-F), indicating that the degree of phosphorylation of this site is likewise proportional to the amount of cyclin present. This result does not distinguish between a cyclin-induced phosphorylation of p34cdc2 on peptides 4 and 5 and a stabilization by cyclin binding of the phosphorylated form in rapid equilibrium with the unphosphorylated state. (A similar hypothesis for the cyclin-iduced phosphorylation of Tyr-15 was previously excluded because such phosphorylation did not occur after vanadate treatment alone [Solomon et al., 1990] .) This constitutive phosphorylation would have to be extremely low because it has never been observed, even at very high specific activity labelings, and because the extent of phosphorylation is proportional to even the lowest concentrations of cyclin ( Figure 6F) . A further experiment also suggested that Thr-161 is not phosphorylated in . However, no phosphorylation of p34Cdc2 was trapped even in the presence of a high concentration of okadaic acid, sufficient to also inhibit type 1 phosphatases (Figure 7 , lane 2). In contrast, p34cdc2 was strongly phosphorylated by addition of GT-cyclin B (Figure 7, lane 3) . We cannot yet distinguish between phosphorylation after cyclin binding and phosphorylation coupled to binding.
Is Thr-161 Phosphorylation an Intramolecular Event?
The proximity of Thr-161 to the autophosphorylation sites found in a number of kinases (Hanks et al., 1988) has led to the suggestion that p34cdc2 might also autophosphorylate (Krek and Nigg, 1991 ). This possibility was tested by determining the phosphorylation capability of an inactive p34c c2 mutant. Lys-33 of p34cdc2 aligns with a lysine found in all kinases that is essential for binding ATP (Hanks et al., 1988; Knighton et al., 1991) . Mutation of Lys-33 to Arg abolished p34cdc2 activity whereas the adjacent K34R mutation had no effect ( Figure 2B, lanes 3 and 4) . Reticulocyte lysate-produced p34cdc2 and to the endogenous p34cdc2 (Figure 4 ). Thus sites of phosphorylation determined. The labeling of these mutants was identical to an added wild-type p34cdc2 and to the endogenous p34cdc2 (Figure 8) Figure   9A , lanes 9 and 10). The Hi kinase activity in the absence of added p34cdc2 ( Figure 9A , lanes 1-3) was due to activation of the endogenous p34cdc2. Similarly, a mitotic extract partially activated the added p34cdc2 at a dilution of 81-fold ( Figure 9B, lane 10) . Little or no Hi kinase activity was detectable at comparable dilutions in the absence of added p34cdc2 ( Figure 9B , lanes 1-5).
A slightly more dilute extract prepared from prophase arrested oocytes had comparable activity ( Figure 9C ).
This activity has been termed the dip34Cdc2 activating kinase" (or CAK) on the basis of data presented below ( Figure 11 ).
We have partially purified the p34Cdc2 activating kinase 100-fold on the basis of its ability to activate exogenous p34cdc2. The starting material was an interphase extract because it is simple to prepare and because CAK activity is no higher in other extracts. In brief, the extract was diluted and centrifuged to remove a large mass of yolk proteins and other aggregates. The supematant was applied to a DEAE-Sepharose column and eluted with a NaCl gradient. The Figure 9. Activity of the p34cdc2 activating kinase in interphase, mitotic, and oocyte extracts. An interphase extract (A, -70 mg/ml) was serially diluted threefold into EB (lanes 1-5 and lanes 6-10). These samples were incubated with reticulocyte lysates containing p34cdc2 and GT-cyclin B (lanes 6-10) or just with GT-cyclin B (lanes 1-5) and assayed for Hi kinase activity. Lanes 1 and 6 contained the undiluted extract and lanes 5 and 10 contained extract diluted 81-fold. A mitotic extract produced by incubating an interphase extract with 450 nM GT-cyclin B for 30 min was similarly diluted and assayed (B). An oocyte extract (Cyert and Kirschner, 1988) ('-14 mg/ml) was similarly diluted and assayed with GT-cyclin B alone (lanes 1-4) or with a reticulocyte lysate containing p34Cdc2 in addition (lanes 5-10). See MATERIALS AND METHODS for further details.
-200 kDa. Even the most highly enriched fractions still contained a complex mixture of proteins. Figure 10 shows the fractionation on a DEAE-Sepharose column. All the applied CAK activity bound to the column (IN), although half the total protein flowed through. Activity eluted fairly sharply during a linear salt gradient, with a peak at the fairly low NaCl concentration of -115 mM. There was near quantitative recovery of CAK activity and a purification of about sixfold.
Partially purified CAK (purified through the ammonium sulfate step) was used to determine its substrate requirements (Figure 11 ). Wild-type p34Cdc2 -was immunoprecipitated from reticulocyte lysates and incubated with [ -32P)ATP, GT-cyclin B, and CAK ( Figure   11 , lane 2). p34cdc was phosphorylated as was a protein tentatively identified as GT-cyclin B. In the absence of GT-cyclin B there was only a low background phosphorylation of p34cdc2 (Figure 11, lane 3) , presumably on misfolded molecules. CAK is thus a cyclin-dependent p34cdc2 kinase, as predicted from the extract experiments.
The T161A mutant of p34Cdc2 was not significantly phosphorylated ( Figure 11, lane 4) , confirming that the correct site was utilized. Omission of either p34cdc2 (Figure 11, lane 6) or CAK (Figure 11, lane 7) eliminated the observed phosphorylation. Importantly, the catalytically inactive K33R mutant of p34cdc2 was also phosphorylated ( Figure 11, lane 5) , confirming that intramolecular autophosphorylation is not part of this reaction sequence. The same results were seen in the AF mutant background of p34cdc2: phosphorylation of p34cdc2 and of GT-cyclin B (Figure 11 , lane 8) but no phosphorylation of either in the absence of GT-cyclin B or with Ala-161 (Figure 11, lanes 9 and 10) . We tested whether GT-cyclin B was phosphorylated by CAK or whether its phosphorylation depended on the activity of p34cdc2. In all cases, GT-cyclin B only became phosphorylated when p34cdc2 was both phosphorylated and capable of activation; simple phosphorylation of an inactivatable form of p34cdc2 was insufficient to cause GTcyclin B phosphorylation (Figure 11 , lane 5). We conclude that the vast bulk of GT-cyclin B phosphorylation is due to activated p34cdc2 rather than to a component in the CAK preparation.
CAK Activity is not due to a p34cdc2 Protein Kinase We examined the possibility that p34cdc2 could autophosphorylate intermolecularly, i.e., that CAK activity is due to p34cdc2. A number of experiments ruled this out. First, purified Hi kinase had no CAK activity (Figure 12A) . Dilutions of purified Hi kinase were added to a control buffer ( Figure 12A, lanes 1-5) , to an unprogrammed reticulocyte lysate ( Figure 12A , lanes 6-10), or to a reticulocyte lysate containing wild-type Xenopus p34cdc2 (Figure 12A, . No activation of p34cdc2 was detectable; the Hi kinase activity seen was that present in the initial Hi kinase sample itself ( Figure 12A, lanes 1-5) . Second, partially purified CAK contained no Hi kinase activity ( Figure 12B ). Although p34cdc2 activation occurred after CAK dilution of 10-to 270-fold ( Figure 12B, lanes 3-6) , 10-and 30-fold diluted CAK displayed no detectable Hi kinase activity ( Figure   12B, lanes 1 and 2) . Third, incubation of partially purified CAK with p13sucl-Sepharose beads depleted p34cdc22-like proteins but had no effect on CAK activity (Figure 12, C and D) . pl3sucl binds to p34cdc2 and very close family members from all species examined (Brizuela et al., 1987; Dunphy et al., 1988; Solomon et al., 1990) . Dilutions of CAK were assayed alone ( Figure  12C, lanes 1-4) , or after incubation with control protein A-Sepharose beads ( Figure 12C, lanes 5-8) , or after incubation with p13sucl-Sepharose beads ( Figure 12C , lanes 9-12). There was no detectable difference in activity other than the small dilution of both samples that had been incubated with beads (compare Figure 12C Fraction (no.) Figure 10 . DEAE-Sepharose chromatography of the p34cdc2 activating kinase. A clarified interphase extract was applied to a DEAE-Sepharose column as described in MATERIALS AND METHODS and eluted with a linear NaCl gradient from 50 mM in fraction 20 to 345 mM in fraction 45. Fractions were assayed for CAK activity (gel insert) and for total protein (graph; see MATERIALS AND METHODS). Fractions 23-28 were pooled (hatched area) following reassay of diluted fractions to more accurately determine the peak of activity.
Western blotting with an anti-PSTAIR antiserum that detects p34cdc2 and closely related proteins showed that the bulk of p34cdc2 purified away from CAK activity Figure 12D , lane 4) along with more of a protein with greater electrophoretic mobility, presumably Egl (CDK2) (Solomon et al., 1990; Paris et al., 1991) , and some minor proteins with mobilities similar to p34cdc2. These proteins were enriched by ammonium sulfate precipitation of CAK activity ( Figure 12D , lane 5). The pooled DEAE eluate that was incubated with protein A-and p13sucl-Sepharose beads ( Figure 12C ) was analyzed by Western blotting for p34cdc2-related proteins ( Figure 12D , lanes 6-9 and 10-13). No p34cdc-related proteins bound to the protein A-Sepharose beads ( Figure 12D , lanes 7 and 11) whereas all of the Egl (CDK2) and some of the minor proteins bound quantitatively to p13sucl ( Figure 12D , lanes 9 and 13). We assume that the minor proteins that do not bind to p13suc" ( Figure 12D , lanes 8 and 12) do not represent forms of p34Cdc2 because both p34cdc2 and Egl bind tightly to p13Suc1 (Brizuela et al., 1987; Dunphy et al., 1988; Solomon et al., 1990) and because Egl has been quantitatively depleted by p13sucl in this experiment. These proteins may be more distantly related members of the p34cdc2 family of protein kinases that contain recognizable "PSTAIR" sequences. It will be interesting to follow these proteins during further purification.
DISCUSSION p34cdc2 Phosphorylation Sites
The synthesis of cyclin is not sufficient to generate the mitotic state. Several phosphorylation events are interspersed between cyclin binding and p34cdc2 activation.
These phosphorylation reactions govern the entry into mitosis and provide important targets for feedback regulation. The identification of the enzymes responsible for regulating these phosphorylation events has been difficult. The weel and/or mikl (Lundgren et al., 1991) proteins may phosphorylate the inactivating sites (Featherstone and Russell, 1991; Parker et al., 1991) , although direct evidence is lacking. cdc25 is now thought to be the protein tyrosine phosphatase that acts on the same sites Strausfeld et al., 1991 Figure 3 ). The sites of phosphorylation were already known to reside on the same tryptic peptide (Solomon et al., 1990) , which, as it turns out, contains a single threonine and two tyrosines (Milarski et al., 1991) .
Added wild-type p34cdc2 ("TY") gave rise to two electrophoretically retarded forms, a single mutant ("AY") gave rise to a single electrophoretically retarded form, and the double "AF" mutant could not be phosphorylated and gave rise to no new forms. Direct 32P-labeling of the T14A mutant confirmed the assignments and clearly demonstrated the phosphorylation of this site. Thr-161 was shown to be a likely site of ohosphorylation by direct 32P-labeling of mutant p34cc proteins:
phosphorylation of this site in both a vanadate-arrested extract and in a mitotic extract was eliminated by a T161A mutation. We cannot yet exclude the remote possibility that Thr-161 is not phosphorylated and that mutation of Thr-161 to nonphosphorylatable amino acids actually prevents phosphorylation at another threonine in the p34cdc2 molecule. We assume for now that Thr-161 is indeed phosphorylated. Experiments are in progress to resolve this issue. Evidence presented here and elsewhere indicates that a type A cyclin protein induces phosphorylation of the same sites and acts through the same pathway. We have suggested that differences in subcellular localization, rather than biochemistry, determine the different activation pathways followed by cyclin A-and cyclin Bp34cdc2 complexes .
Three factors were necessary for our ability to determine these phosphorylation sites: recombinant p34cdc2 mutants, high stoichiometry labeling resulting from high concentrations of added cyclin, and the defined arrest points resulting from vanadate treatment ("late G2") and a nondegradable cyclin (mitosis activating kinase (through DEAE chromatography) was left untreated (lanes 1-4) or incubated with control protein A-Sepharose beads (lanes 5-8) or with pl3sucl-Sepharose beads (lanes 9-12). Supernatants were left undiluted (lanes 1, 5, and 9) or diluted 3-fold (lanes 2, 6, and 10), 9-fold (lanes 3, 7, and 11), or 27-fold (lanes 4, 8, and 12) into EB/1 mg/ml ovalbumin and assayed for their ability to activate p34cdc2 in reticulocyte lysates. Lanes 1-4 contained about twice as much protein as the corresponding lanes 5-8 and 9-13. (D) Immunoblot of p34cdc2 related proteins during purification of the p34cdc2 activating kinase. Lane 1, 2 ng of reticulocyte lysate produced p34 C12. Lane 2, 10 ,g of the input to the DEAE column. Lane 3, Flow-through from the DEAE column. Lane 4, 10 Ag of pooled peak fractions from the DEAE column. Lane 5, 10 ,gg of 0-38% ammonium sulfate fraction of the DEAE peak. Lanes 6-9, supernatant (lanes 6 and 8) and pellet (lanes 7 and 9) fraction after incubation of 10 sg of the pooled DEAE peak with protein A-Sepharose (lanes 6 and 7) or with p13sucl-Sepharose (lanes 8 and 9). Lanes 10-13 show a longer exposure of lanes 6-9.
1989; Krek and Nigg, 1991) . Thr-161 may be a site of phosphorylation in chicken p34cdc2 (Krek and Nigg, 1991 ) and the homologous Thr-167 is probably used in S. pombe p34cdc2 (cited in Krek and Nigg, 1991) . We have never seen evidence for phosphorylation of Ser-277 as occurs in chicken p34cdc (Krek and Nigg, 1991) .
A possible explanation is that the early embryonic Xenopus cell cycle lacks a Gl phase, the time at which phosphorylation of this site is highest (Krek and Nigg, 1991) .
The Roles of Phosphorylation in p34cdc2 Activation
Phosphorylation of Thr-14 and Tyr-15 negatively regulate p34cdc2 activity (see RESULTS), whereas phosphorylation of the activating site, assumed to be Thr-161, is absolutely required for its kinase activity (see Figure 2) . Mutagenesis of S. pombe Tyr-15 also indicates that this phosphorylation plays a negative role (Gould and Nurse, 1989 (Booher and Beach, 1986 ). (Figure 1 ) and to forms of p34cdc2 mutated at Thr-161 ( Figure 5 ), phosphorylation of this site is not required for this association. Although a strong case can be made that any cyclin-induced phosphorylation of p34cdc2 must increase the affinity of p34cdc2
for cyclin, it appears that the interaction between Xenopus p34cdc2 and GT-cyclin B is sufficiently strong to occur in the absence of phosphorylation (see Figure   5 ). Binding of cyclin B to p34Cdc2 is, however, insufficient for kinase activity (see Figure 2A ). (Figure 7) . Furthermore, the g34cc2 activating kinase does not phosphorylate p34C c2 in the absence of cyclin, even in a more purified system presumably deficient in phosphatase activities (Figure 11 ). Induced autophosphorylation also does not seem to be operative. We have no evidence that autophosphorylation ever occurs (Figures 8, 11 , and 12). Moreover, the p34cdc2 activating kinase exists and is capable of phosphorylating the correct site in a catalytically inactive form of p34 cd in the presence of GT-cyclin B (Figure 11 ).
The sequence of phosphorylations is not yet clear but their dependencies are. The activating phosphorylation depends on cyclin binding and does not require activation of the mitotic state. All three phosphorylations are thus dependent on cyclin binding (Solomon et al., 1990 ) and may reflect a common induced conformational change that makes these sites accessible to the appropriate kinases. The activating phosphorylation also does not depend on Thr-14 and/or Tyr-15 phosphorylation (Figures 2 and 11) . Similarly, Thr-14 and Tyr-15 phosphorylation do not depend on the activating phosphorylation (Figures 3 and 4) . The extent of the activating phosphorylation does not appear to be regulated by entry into mitosis to produce an autoactivating process. In contrast, entry into mitosis does regulate phosphorylation through both the kinase and the phosphatase reactions (Solomon et al., 1990) . All of this suggests independent regulation of the activating and inhibitory phosphorylations and leaves unclear the role of cyclin phosphorylation (see als3 Izumi and Maller, 1991) .
A J/p34cdc2 Kinase"
A new and central component in the regulatory network is the kinase that phosphorylates p34cdc on its activating site, probably Thr-161. We found that this phosphorylation does not occur by either intramolecular or intermolecular autophosphorylation; instead, a cellular activity is required. There are no obvious genetic candidates for this enzyme, which could suggest that it has multiple roles in cell physiology. We have termed this enzyme the p34cdc2 activating kinase (CAK) on the basis of its ability to directly phosphorylate and activate p34cdc2 in the presence of cyclin. Properly speaking, this enzyme is a p34cdc2 kinase, although use of that term would likely cause confusion. Although unlikely, it remains formally possible that CAK is an activator, rather than a kinase, and that the K33R mutant of p34cdc2 retains the ability to be induced to autophosphorylate. We have purified CAK over 100-fold. The enzyme does not require cofactors such as Ca2" or cAMP (Figure 11 ).
The level of CAK activity appears to be the same in interphase, mitosis, and prophase extracts from oocytes. This invariance is striking in light of the crucial role this phosphorylation plays in p34c c2 activation. Despite this, control of the extent of Thr-161 phosphorylation is an attractive route for regulation of p34Cdc2 activity in response to feedback or checkpoint controls during the cell cycle. Further efforts to purify and identify the p34cdc2 activating kinase and to study its regulation under other cell cycle conditions should yield insights into the coordination of p34cdc2 activity with cellular signals.
